Search research articles
Contact Us
Filters
Showing results (611-620 of 912) with videos related to
Page
of 92
Sort By:
Journal of Medicinal Chemistry
|
March 12, 1999
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines
A G Arvanitis, P J Gilligan, R J Chorvat, et al.
Communications Earth & Environment
|
December 4, 2025
Alteration history of aluminum-rich rocks at Jezero crater, Mars
A P Broz, B H N Horgan, C Bedford, et al.
Elife
|
January 9, 2025
A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
David Trombley McSwiggen, Helen Liu, Ruensern Tan, et al.
European Journal of Endocrinology
|
May 19, 2012
Predictors of morbidity and mortality in acromegaly: an Italian survey
M Arosio, G Reimondo, E Malchiodi, et al.
Journal of Medicinal Chemistry
|
March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines
R J Chorvat, R Bakthavatchalam, J P Beck, et al.
Journal of Medicinal Chemistry
|
April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitors
Felix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Neuropharmacology
|
November 6, 2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders
Robert F Bruns, Stephen N Mitchell, Keith A Wafford, et al.
Bioorganic & Medicinal Chemistry
|
December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints
Leonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Journal of Medicinal Chemistry
|
March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres
Ana Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry
|
June 3, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor
David L McKinzie, Leonard L Winneroski, Steven J Green, et al.
Page
of 92
Search research articles
Search
Showing results (611-620 of 912) with videos related to
Sort By:
Page
of 92
Journal of Medicinal Chemistry
|
March 12, 1999
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines
A G Arvanitis, P J Gilligan, R J Chorvat, et al.
Communications Earth & Environment
|
December 4, 2025
Alteration history of aluminum-rich rocks at Jezero crater, Mars
A P Broz, B H N Horgan, C Bedford, et al.
Elife
|
January 9, 2025
A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
David Trombley McSwiggen, Helen Liu, Ruensern Tan, et al.
European Journal of Endocrinology
|
May 19, 2012
Predictors of morbidity and mortality in acromegaly: an Italian survey
M Arosio, G Reimondo, E Malchiodi, et al.
Journal of Medicinal Chemistry
|
March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines
R J Chorvat, R Bakthavatchalam, J P Beck, et al.
Journal of Medicinal Chemistry
|
April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitors
Felix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Neuropharmacology
|
November 6, 2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders
Robert F Bruns, Stephen N Mitchell, Keith A Wafford, et al.
Bioorganic & Medicinal Chemistry
|
December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints
Leonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Journal of Medicinal Chemistry
|
March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres
Ana Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry
|
June 3, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor
David L McKinzie, Leonard L Winneroski, Steven J Green, et al.
Page
of 92